Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1425 of 3546 entries
View as:

Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania

Phase: N/A Priority: Normal
NCT ID: NCT01253967 Org: User:
Start: 02/29/08 End: 01/31/10 Due: 01/31/11

An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01536418 Org: User:
Start: 11/11/11 End: 10/17/13 Due: 10/17/14

A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine

Phase: N/A Priority: Normal
NCT ID: NCT01962467 Org: User:
Start: 10/11/13 End: 02/27/14 Due: 02/27/15

Oral GW766944 (Oral CCR3 Antagonist)

Phase: N/A Priority: Normal
NCT ID: NCT01160224 Org: User:
Start: 09/08/10 End: 08/29/11 Due: 08/29/12

GSK2339345 Hypertussive Challenge Study

Phase: N/A Priority: Normal
NCT ID: NCT01899768 Org: User:
Start: 11/30/13 End: 10/31/14 Due: 10/31/15

Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT02082665 Org: User:
Start: 02/19/15 End: 08/01/16 Due: 08/01/17

A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT02603172 Org: User:
Start: 05/12/16 End: 05/10/17 Due: 05/10/18

Safety, Blood Levels and Effects of GW642444

Phase: N/A Priority: Normal
NCT ID: NCT00469040 Org: User:
Start: 02/28/07 End: 04/16/07 Due: 04/16/08

A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT00549653 Org: User:
Start: 10/31/07 End: 12/31/07 Due: 12/31/08

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00376779 Org: User:
Start: 10/31/06 End: 05/31/07 Due: 05/31/08

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00733551 Org: User:
Start: 09/23/08 End: 07/20/09 Due: 07/20/10

Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01607086 Org: User:
Start: 07/11/08 End: 07/18/08 Due: 07/18/09

Motivation, Brain Function and Mood in Individuals With Cold and/or Flu

Phase: N/A Priority: Normal
NCT ID: NCT02860169 Org: User:
Start: 03/11/16 End: 11/24/16 Due: 11/24/17

Fibromyalgia Study In Adults

Phase: N/A Priority: Normal
NCT ID: NCT00256893 Org: User:
Start: 11/30/04 End: 07/31/05 Due: 07/31/06

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01847417 Org: User:
Start: 05/16/13 End: 07/01/13 Due: 07/01/14

An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184

Phase: N/A Priority: Normal
NCT ID: NCT01777256 Org: User:
Start: 03/01/13 End: 03/31/14 Due: 03/31/15

A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01428453 Org: User:
Start: 10/01/11 End: 02/18/13 Due: 02/18/14

First Time in Human Study

Phase: N/A Priority: Normal
NCT ID: NCT01031186 Org: User:
Start: 11/23/09 End: 04/07/10 Due: 04/07/11

A Proof-of-principle Clinical Study Investigating the Efficacy of an Experimental Dentifrice Containing Sodium Bicarbonate and Sodium Hyaluronate on Gingivitis

Phase: N/A Priority: Normal
NCT ID: NCT04737538 Org: User:
Start: 02/10/21 End: 07/28/21 Due: 07/28/22

GW572016 In Patients With Advanced Or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00462956 Org: User:
Start: 06/30/04 End: 12/20/06 Due: 12/20/07

A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01691547 Org: User:
Start: 12/17/12 End: 03/08/13 Due: 03/08/14

A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model

Phase: N/A Priority: Normal
NCT ID: NCT00731250 Org: User:
Start: 07/22/08 End: 03/31/09 Due: 03/31/10

A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)

Phase: N/A Priority: Normal
NCT ID: NCT01669070 Org: User:
Start: 08/15/12 End: 11/16/12 Due: 11/16/13

Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT01827670 Org: User:
Start: 02/28/13 End: 05/31/13 Due: 05/31/14

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT02242643 Org: User:
Start: 10/01/14 End: 06/23/15 Due: 06/23/16